BioPharma Credit PLC (BPCR) — Financial Flexibility Index
BioPharma Credit PLC (BPCR) has a Financial Flexibility Index of 4.50x as of June 2025. Free cash flow of $33.76 Million (operating CF $33.76 Million minus capex $0.00) represents 5% of total liabilities ($7.49 Million). Also explore BioPharma Credit PLC (BPCR) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BioPharma Credit PLC Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for BioPharma Credit PLC across 8 annual periods. Check BPCR capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for BioPharma Credit PLC (2017–2024)
Year-by-year free cash flow to debt coverage for BioPharma Credit PLC. For the full company profile including market capitalisation, see BioPharma Credit PLC market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 6.24x | $111.91 Million | $111.91 Million | $17.94 Million | ▼ -19.6% |
| 2023 | 7.76x | $123.18 Million | $123.18 Million | $15.87 Million | ▲ +10.8% |
| 2022 | 7.01x | $184.28 Million | $184.28 Million | $26.30 Million | ▼ -49.9% |
| 2021 | 13.98x | $96.44 Million | $96.44 Million | $6.90 Million | ▲ +126.1% |
| 2020 | 6.18x | $58.07 Million | $58.07 Million | $9.39 Million | ▲ +18.6% |
| 2019 | 5.21x | $131.52 Million | $131.52 Million | $25.23 Million | ▲ +2.9% |
| 2018 | 5.07x | $67.14 Million | $67.14 Million | $13.25 Million | ▼ -36.0% |
| 2017 | 7.91x | $23.07 Million | $23.07 Million | $2.92 Million | — |